Low maternal PAPP‐A is associated with small‐for‐gestational age newborns and stillbirths
- 1 September 2010
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 89 (9) , 1226-1228
Abstract
We investigated the association of first trimester low maternal serum pregnancy‐associated plasma protein‐A (PAPP‐A) levels with small‐for‐gestational age (SGA) newborns and stillbirths (SBs) in a retrospective national population‐based register study. The study group comprised 921 women with the lowest 5% PAPP‐A levels (≤0.3 MoM) and the control group comprising 18,615 women with PAPP‐A levels >0.3 MoM. In the study group there were 35 (3.8%) and in the control group 213 SGA newborns (1.1%), respectively (OR, 3.41; 95% CI, 2.37–4.91). There were 9 (1.0%) and 51 (0.3%) cases of SBs in the study and control groups, respectively (p < 0.002; OR, 3.59; 95% CI, 1.76–7.32). Low PAPP‐A is a risk factor for SGA and SB.Keywords
This publication has 10 references indexed in Scilit:
- First trimester maternal serum PAPP‐A, β‐hCG and ADAM12 in prediction of small‐for‐gestational‐age fetusesPrenatal Diagnosis, 2008
- Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: Systematic review and meta-analysisBMC Pregnancy and Childbirth, 2008
- First-trimester pregnancy-associated plasma protein A and subsequent abnormalities of fetal growthAmerican Journal of Obstetrics and Gynecology, 2008
- Use of the combined first‐trimester screen result and low PAPP‐A to predict risk of adverse fetal outcomesPrenatal Diagnosis, 2008
- Maternal Smoking and Fetal Growth Characteristics in Different Periods of Pregnancy: The Generation R StudyAmerican Journal of Epidemiology, 2007
- Multicenter study of first‐trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk‐orientated two‐stage first‐trimester screeningUltrasound in Obstetrics & Gynecology, 2005
- Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2004
- Early Pregnancy Levels of Pregnancy-Associated Plasma Protein A and the Risk of Intrauterine Growth Restriction, Premature Birth, Preeclampsia, and StillbirthThe Journal of Clinical Endocrinology & Metabolism, 2002
- Appropriate biochemical parameters in first-trimester screening for Down syndromePrenatal Diagnosis, 1999
- The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-AProceedings of the National Academy of Sciences, 1999